Home page > About us > Finances and Funding

Finances and Funding

The SFP operates with minimal administrative costs allowing most of its received funds to go directly to supporting information and advocacy work, publications and workshops.

To ensure that the SFP continues to be independent and flexible, it mainly receives income from its Partners. In 2009, the SFP received direct contributions from Cancer Research UK (CR UK), the European Heart Network (EHN), the European Respiratory Society (ERS), and the Institut National du Cancer (INCa).

In 2009, the SFP managed the funds from the Tobacco Free Europe Campaign and received €5,000 from ECL, €5,000 from EHN, €1,000 from ENSP, and €1,000 from ERS. Three unrestricted educational grants were also received (€30,000 from Novartis, €30,000 from Pfizer and €5,000 from Johnson and Johnson) to finance the activities linked to the Tobacco Free Europe Campaign. The Campaign and the funds will continue to be used in 2010.

Please see the 2009 SFP Annual Report for detailed information on SFP expendidures and income in 2009.

And please see here for the 2008 SFP Annual Report , where SFP income and expenditures from 2008 can be seen.